| Schedule of Share Capital and Additional Paid in Capital |
| | |
Number of
ordinary
shares | | |
Nominal value of ordinary
shares | | |
Share
capital | | |
Subscription receivable | | |
Treasury shares | | |
Warrant outstanding | | |
Additional
paid-in capital | | |
Total | |
| | |
| | |
US$ | | |
RMB’000 | | |
RMB’000 | | |
RMB’000 | | |
RMB’000 | | |
RMB’000 | | |
RMB’000 | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| |
| At January 1, 2024 | |
| 2,455,202,303 | | |
| 24,552,023 | | |
| 165,183 | | |
| (4,696 | ) | |
| — | | |
| — | | |
| 7,196,341 | | |
| 7,356,828 | |
| Issuance of shares, net (ii) | |
| 47,619,050 | | |
| 476,191 | | |
| 3,380 | | |
| — | | |
| — | | |
| 29,587 | | |
| 1,145 | | |
| 34,112 | |
| Share-based compensation from ESOP (Note 26) | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 161,231 | | |
| 161,231 | |
| Share-based compensation from controlling shareholder ESOP (Note 26) | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (810 | ) | |
| (810 | ) |
| Conversion of convertible bonds to shares (i) | |
| 27,888,690 | | |
| 278,887 | | |
| 1,982 | | |
| — | | |
| — | | |
| — | | |
| 27,803 | | |
| 29,785 | |
| Exercise of options | |
| 226,848,352 | | |
| 2,268,483 | | |
| 16,133 | | |
| — | | |
| — | | |
| — | | |
| (8,159 | ) | |
| 7,974 | |
| Capital contributions from non-controlling shareholders | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 12,133 | | |
| 12,133 | |
| Repurchase of own shares | |
| (63,358,000 | ) | |
| (633,580 | ) | |
| — | | |
| — | | |
| (6,862 | ) | |
| — | | |
| — | | |
| (6,862 | ) |
| At December 31, 2024 | |
| 2,694,200,395 | | |
| 26,942,004 | | |
| 186,678 | | |
| (4,696 | ) | |
| (6,862 | ) | |
| 29,587 | | |
| 7,389,684 | | |
| 7,594,391 | |
| | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| At January 1, 2025 | |
| 2,694,200,395 | | |
| 26,942,004 | | |
| 186,678 | | |
| (4,696 | ) | |
| (6,862 | ) | |
| 29,587 | | |
| 7,389,684 | | |
| 7,594,391 | |
| Issuance of shares, net (ii) | |
| 31,018,781,200 | | |
| 32,455,588 | | |
| 232,977 | | |
| (133,667 | ) | |
| — | | |
| — | | |
| 33,209 | | |
| 132,519 | |
| Share-based payments from the Company (Note 26) | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (18,239 | ) | |
| (18,239 | ) |
| Share-based payments from the controlling shareholder (Note 26) | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 734 | | |
| 734 | |
| Exercise of options | |
| 63,615,000 | | |
| 636,150 | | |
| 4,557 | | |
| — | | |
| — | | |
| — | | |
| (4,500 | ) | |
| 57 | |
| Shares cancellation | |
| (2,708 | ) | |
| (27 | ) | |
| — | * | |
| — | | |
| — | | |
| — | | |
| — | * | |
| — | |
| Reduction of par value(iii) | |
| — | | |
| (59,999,938 | ) | |
| (423,973 | ) | |
| — | | |
| 6,861 | | |
| — | | |
| 417,112 | | |
| — | |
| At December 31, 2025 | |
| 33,776,593,887 | | |
| 33,777 | | |
| 239 | | |
| (138,363 | ) | |
| (1 | ) | |
| 29,587 | | |
| 7,818,000 | | |
| 7,709,462 | |
| * | Representing
an amount with an absolute value of less than RMB1,000 (including negative amounts). |
| (i) | During the year ended December 31, 2024, the Company issued 27,888,690 Class A ordinary shares upon the conversion of certain convertible bonds issued to LMR in aggregate (Note 18). |
| (ii) | In
March 2024, the Company issued to certain institutional investors 47,619,050 Class A ordinary shares together with warrants to purchase
up to 47,619,050 Class A ordinary shares through a private placement for a total net proceeds of approximately RMB34.1 million, after
deducting commissions and other offering expenses. The warrants were exercisable beginning six months following the date of issuance
and will expire five years from the initial exercise date. The Company also issued warrants to initially purchase up to 2,380,950 Class
A ordinary shares to a financial advisor in connection with this registered direct offering. |
| (iii) | In October 2025, the Company announced that shareholders of
the Company approved a special resolution to amend the par value of each authorized share in the capital of the Company (including all
issued shares) from US$0.01 to US$0.000001. |
|